Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AT2220 and alglucosidase alfa drug-drug interaction study in adults with Pompe disease
2011-002154-32Phase 2Completed
- Sponsor
- Amicus Therapeutics
- Start
- Oct 2011
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of duvoglustat, alglucosidase alfa in Pompe disease, sponsored by Amicus Therapeutics. Started Oct 2011; status: completed.
02
Drugs
duvoglustatalglucosidase alfa
03
Conditions
Pompe disease
Beyond the preview
Go deeper on 2011-002154-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002154-32.